Title : mTORC1 is a key mediator of RON-dependent breast cancer metastasis with therapeutic potential.

Pub. Date : 2018

PMID : 30456298






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Finally, inhibition of mTORC1 with an FDA-approved drug, everolimus, resulted in transient shrinkage of established RON-dependent metastases, and combined blockade of mTORC1 and RON delayed progression. Everolimus CREB regulated transcription coactivator 1 Mus musculus